EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR).
about
Stem cell transplantation for systemic sclerosis2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitisMy approach to the treatment of sclerodermaManagement of Systemic-Sclerosis-Associated Interstitial Lung DiseaseTrends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studiesSystemic sclerosis: commonly asked questions by rheumatologistsSpotlight on tocilizumab and its potential in the treatment of systemic sclerosisAn Update on the Treatment of the Cutaneous Manifestations of Systemic Sclerosis: The Dermatologist's Point of View.Multicentre randomised placebo-controlled trial of oral anticoagulation with apixaban in systemic sclerosis-related pulmonary arterial hypertension: the SPHInX study protocolThe Scleroderma Patient-centered Intervention Network (SPIN) Cohort: protocol for a cohort multiple randomised controlled trial (cmRCT) design to support trials of psychosocial and rehabilitation interventions in a rare disease context.Correlations between changes in cytokines and clinical outcomes for early phase (proof of concept) trials in active diffuse systemic sclerosis using data from an imatinib study.Therapy for pulmonary arterial hypertension associated with systemic sclerosis.Diagnosis and management of pulmonary hypertension in systemic sclerosis.Treatment of connective tissue disease-associated interstitial lung disease: the pulmonologist's point of view.Scleroderma lung diseaseInterstitial lung disease: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases.Registry evaluation of digital ulcers in systemic sclerosis.Raynaud's phenomenon, inflammatory arthritis, and weight loss: pay attention to the man behind the curtain.[The German network for systemic sclerosis (DNSS): current data on diagnostics and therapy].Emerging targets for the treatment of scleroderma.The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab.Phosphodiesterase-5 inhibitors for the treatment of secondary Raynaud's phenomenon: systematic review and meta-analysis of randomised trials.Lidocaine for systemic sclerosis: a double-blind randomized clinical trial.Advances in the evaluation and management of esophageal disease of systemic sclerosis.[Oral N-acetylcysteine in the treatment of Raynaud's phenomenon secondary to systemic sclerosis: a randomized, double-blind, placebo-controlled clinical trial].Vascular involvement in systemic sclerosis (scleroderma).Safety and effectiveness of mycophenolate in systemic sclerosis. A systematic reviewPulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS): baseline characteristics and description of study population.Primary biliary cirrhosis associated with systemic sclerosis: diagnostic and clinical challenges.Reactivity of pulmonary circulation and right ventricle function to inhaled nitric oxide in systemic sclerosis patientsInterstitial Lung Disease in Children Older Than 2 Years.Tocilizumab for the treatment of rheumatoid arthritis and other systemic autoimmune diseases: current perspectives and future directions.Cardiac metabolomics and autopsy in a patient with early diffuse systemic sclerosis presenting with dyspnea: a case report.Treprostinil Iontophoresis Improves Digital Blood Flow during Local Cooling in Systemic Sclerosis.Prevalence and predictive factors of osteoporosis in systemic sclerosis patients: a case-control study.Old medications and new targeted therapies in systemic sclerosis.Pediatric scleroderma: systemic or localized formsSafety, tolerability and potential efficacy of injection of autologous adipose-derived stromal vascular fraction in the fingers of patients with systemic sclerosis: an open-label phase I trialPatients' views and needs about systemic sclerosis and its management: a qualitative interview study.Diagnosis and treatment of connective tissue disease-associated interstitial lung disease.
P2860
Q24187598-F4D906EC-F145-4ACE-BBF5-6E922412F989Q24603648-661FA170-4630-49DA-A716-BCD29735F579Q24618843-22408DBB-0010-4435-A9CF-E156C6E2B54DQ26799573-F015B730-922E-4A9B-AD5A-51FD93786E20Q26864958-98E8D6FF-4168-4B23-A3DC-AA38525B2495Q27021067-A0FE0A3C-6B9D-4755-A777-43F69558C695Q28073706-C13619C6-30C7-4B31-948E-7F18E1A16088Q30465733-733C9327-59B3-4761-B0C6-DE91857EB7DAQ30490484-A5DEA411-EFFD-4322-87B7-45641CD27FF5Q30542602-50DF5F37-FB63-4062-A8F5-3F956D053E63Q30825417-C35A96D5-7C7F-4ADA-91C5-D8575ABFA3B5Q33805746-F4EEF128-855D-4454-A406-876D7D13AA73Q33832379-2F3AEBB6-B186-4DF0-B444-E9B2CD31ACB1Q33907242-9A5EE24F-FF9F-45EE-B967-86B76813ADC8Q33919119-38D5F573-0673-47CA-A803-3A38797C8F47Q33956830-8D6A9D5A-9F19-41E1-93FF-DD64E15C38E6Q34123635-235B6FBD-E388-4D32-A97D-E2CFFA1384BCQ34128485-AAE096C0-3479-406A-AC01-55BB9C0D6A26Q34250693-696D6B54-5210-4AA8-ACF2-4A44B5CDD33DQ34270856-FCA8814B-0C7F-4DF7-8DF5-5A36B51C13D4Q34310749-F9FA76C6-7141-46EB-A042-5215324D15EEQ34328778-43F13898-AA09-4103-B08D-BD6A90A9687CQ34585544-AD94A879-E523-4EC5-8170-C11249C54CF4Q34666835-985FA20C-F8A7-44BA-B3E7-5566BEC9CD15Q35472514-C50926AA-AE57-47DC-86F2-C0A0E902DCE5Q35557424-43C3C552-494F-48C9-8083-73EAED7D149AQ35560664-330357B1-0E9F-43B4-A43C-8BD9854849D1Q35591616-58EFD813-6133-48AD-9E25-1B624E9BDB1DQ35609106-0351130D-7C76-4AFD-A34C-115FF192C03DQ35644221-56DE9959-785E-48C0-9DD5-9791366448FDQ35716057-A60CBDB3-7103-42A8-BAC6-47E935E56024Q35724900-B43A6271-109D-4B35-8FAE-C105443CC793Q35748126-CE5418FB-1E69-4A71-A196-D57AB0305577Q35911465-A89EE09A-99E3-421A-BCAE-AD3E065C5424Q36020862-1AD92B9D-BBFD-41C7-AF36-7EDAFA81C281Q36154430-892CD2F2-3353-4A6B-BD7C-362B94E0C00DQ36282971-0CEFE96C-E902-40EE-BFA5-A9CD1CD0B465Q36374656-C0FC7001-3D5F-4DC5-A270-128553640A62Q36385328-05EFAA54-F5B2-46DD-A3B5-1F084FF3EDF2Q36664408-670882D8-1EB2-4921-A615-7CAA22A1F295
P2860
EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR).
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
EULAR recommendations for the ...... s and Research group (EUSTAR).
@en
EULAR recommendations for the ...... erma Trials and Research group
@nl
type
label
EULAR recommendations for the ...... s and Research group (EUSTAR).
@en
EULAR recommendations for the ...... erma Trials and Research group
@nl
prefLabel
EULAR recommendations for the ...... s and Research group (EUSTAR).
@en
EULAR recommendations for the ...... erma Trials and Research group
@nl
P2093
P50
P356
P1476
EULAR recommendations for the ...... s and Research group (EUSTAR).
@en
P2093
B Garay Toth
EUSTAR Co-Authors
F van den Hoogen
G Valentini
P304
P356
10.1136/ARD.2008.096677
P407
P577
2009-01-15T00:00:00Z